Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Infectious Disease · Pertussis

Recovery & Prevention: The Long Tail and Vaccination

At a Glance

The recovery phase of whooping cough can last for months and may involve complications like rib fractures or secondary infections. The most effective way to prevent the disease in newborns is for mothers to receive a Tdap vaccine between 27 and 36 weeks of pregnancy, combined with vaccinating close family members.

The final stage of whooping cough, the convalescent stage, is often called “the long tail” because while you are no longer contagious, the physical effects of the illness linger for weeks or even months [1][2]. This is a period of healing, but it requires vigilance to prevent complications and a plan to protect those around you.

The Physical Toll of the “Long Tail”

The sheer force of a pertussis cough is unlike a standard cold. The pressure generated during a coughing fit can lead to mechanical injuries that require their own recovery time [3][4].

  • Mechanical Injuries: It is common for patients—both children and adults—to experience rib fractures (often “stress” fractures from repeated force), hernias, or pneumothorax (a collapsed lung) [3][4].
  • Secondary Infections: Your lungs are more vulnerable during this stage. It is common to catch a “regular” cold or viral infection while recovering from pertussis, which can cause the violent coughing fits to temporarily return [5][6].
  • Exhaustion: The weeks of interrupted sleep and physical strain often lead to profound fatigue. Recovery isn’t just about the cough stopping; it’s about your energy levels returning to normal [2].

Why Immunity Fades

You may wonder why you or your child got sick despite being vaccinated. The current acellular pertussis (aP) vaccines are excellent at preventing severe, life-threatening disease, but their protection against “catching” and “spreading” the bacteria wanes (fades) over time [7][8].

  • Waning Immunity: Protection from the vaccine is highest in the first few years and then gradually decreases. This is why cases often spike in teenagers and adults who haven’t had a recent booster [9][10].
  • Evolution: The B. pertussis bacteria have also evolved slightly to try and “hide” from the vaccine’s protection, making regular boosters even more important [11][12].

Protecting the Most Vulnerable

Because infants are too young to be fully vaccinated when born, we use two main strategies to protect them: Maternal Vaccination and Cocooning.

The Gold Standard: Maternal Tdap

The most effective way to protect a newborn is for the mother to receive a Tdap booster during the third trimester of every pregnancy. Ideally, this should be done early in the window between 27 and 36 weeks [13][14].

  • Antibody Transfer: Getting the shot early in this window maximizes the time the mother has to create high levels of antibodies and pass them through the placenta to the baby before birth [15][16].
  • Built-in Protection: This gives the baby “passive immunity” from the moment they are born, protecting them until they can start their own DTaP infant vaccination series (typically given at 2, 4, and 6 months of age) [17][18].

Supporting Defense: Cocooning

Cocooning means making sure everyone who will be around the baby—parents, grandparents, siblings, and childcare workers—is up to date on their Tdap booster [19][20].

  • Creating a Buffer: While not as effective as maternal vaccination on its own, cocooning creates a “buffer zone” of healthy people around the baby to reduce the chance of the bacteria being brought into the home [19][21].
  • Adult Boosters: Adults should generally receive a Tdap booster every 10 years to maintain their protection and help protect the community [22][23].

Navigating Recovery

As you move through the final weeks, remember that the “100-day” timeframe is a biological reality. Focus on avoiding triggers like smoke or cold air that can irritate your sensitive airways, and ensure your “cocoon” is strong by encouraging those around you to stay current with their vaccinations.

Common questions in this guide

How long does it take to recover from whooping cough?
The final recovery phase of whooping cough, often called the "long tail," can last for weeks or even months. During this convalescent stage, you are no longer contagious, but your body needs time to heal from the physical strain.
Can violent coughing from pertussis cause other injuries?
Yes, the immense pressure generated during severe coughing fits can lead to mechanical injuries. It is common for patients to experience rib stress fractures, hernias, or even a collapsed lung due to the force of the cough.
When is the best time to get the Tdap vaccine during pregnancy?
The most effective time to receive a Tdap booster is early in the window between 27 and 36 weeks of every pregnancy. This gives your body the maximum amount of time to build antibodies and pass them to your baby before birth.
What is cocooning for a newborn?
Cocooning involves making sure everyone who will be around the baby—parents, grandparents, siblings, and childcare workers—is up to date on their Tdap booster. This creates a protective buffer around the infant to reduce the chance of whooping cough entering the home.
Why do I need a whooping cough booster as an adult?
The immunity provided by the pertussis vaccine naturally fades over time, and the bacteria has evolved to partially hide from the vaccine. Adults should generally receive a Tdap booster every 10 years to maintain protection and prevent spreading the disease to others.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How can I tell the difference between a normal recovery cough and a secondary infection like pneumonia?
  2. 2.Since I am in the convalescent stage, are there specific activities I should avoid to prevent a relapse in coughing fits?
  3. 3.My cough was very violent; should I be screened for mechanical injuries like a hernia or rib stress fracture?
  4. 4.For my next pregnancy, when exactly is the earliest time in the 27–36 week window to schedule my Tdap vaccine?
  5. 5.If our family is 'cocooning' for a new baby, does everyone need a new booster if they had one five years ago?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice.

    Wu V, Smith AA, You H, et al.

    Mucosal immunology 2016; (9(3)):777-86 doi:10.1038/mi.2015.101.

    PMID: 26462419
  2. 2

    [Features of Bordetella pertussis, Bordetella spp. infection and whopping cough in Córdoba province, Argentina].

    Giayetto VO, Blanco S, Mangeaud A, et al.

    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 2017; (34(2)):108-115 doi:10.4067/S0716-10182017000200002.

    PMID: 28632823
  3. 3

    The potential dangers of whooping cough: a case of rib fracture and pneumothorax.

    Zatovkaňuková P, Slíva J

    BMC infectious diseases 2024; (24(1)):1293 doi:10.1186/s12879-024-10192-8.

    PMID: 39538184
  4. 4

    Multiple rib and vertebral fractures associated with Bordetella pertussis infection: a case report.

    Wang J, Gao J, Fan H, et al.

    BMC infectious diseases 2023; (23(1)):212 doi:10.1186/s12879-023-08189-w.

    PMID: 37024849
  5. 5

    Bordetella Pertussis Infection in Hospitalized Infants with Acute Bronchiolitis.

    Gökçe Ş, Kurugöl Z, Şöhret Aydemir S, et al.

    Indian journal of pediatrics 2018; (85(3)):189-193 doi:10.1007/s12098-017-2480-4.

    PMID: 29076101
  6. 6

    Respiratory bacterial pathogen spectrum among COVID-19 infected and non-COVID-19 virus infected pneumonia patients.

    He F, Xia X, Nie D, et al.

    Diagnostic microbiology and infectious disease 2020; (98(4)):115199 doi:10.1016/j.diagmicrobio.2020.115199.

    PMID: 32979617
  7. 7

    Bordetella and Bronchiolitis: A Chance Association or More Than That?

    Jat KR, Gupta S

    Indian journal of pediatrics 2018; (85(3)):170-171 doi:10.1007/s12098-017-2572-1.

    PMID: 29264828
  8. 8

    What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

    Burdin N, Handy LK, Plotkin SA

    Cold Spring Harbor perspectives in biology 2017; (9(12)) doi:10.1101/cshperspect.a029454.

    PMID: 28289064
  9. 9

    Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.

    Rane MS, Rohani P, Halloran ME

    Vaccine 2021; (39(41)):6144-6150 doi:10.1016/j.vaccine.2021.08.070.

    PMID: 34493409
  10. 10

    Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis.

    Zhu Y, Zhang W, Hu J, et al.

    Human vaccines & immunotherapeutics 2024; (20(1)):2341454 doi:10.1080/21645515.2024.2341454.

    PMID: 38695296
  11. 11

    Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.

    Carriquiriborde F, Regidor V, Aispuro PM, et al.

    Emerging infectious diseases 2019; (25(11)):2048-2054 doi:10.3201/eid2511.190329.

    PMID: 31625838
  12. 12

    Prevalence and characterization of pertactin deficient Bordetella pertussis strains in Brazil, a whole-cell vaccine country.

    Leite D, Camargo CH, Kashino SS, et al.

    Vaccine: X 2021; (8()):100103 doi:10.1016/j.jvacx.2021.100103.

    PMID: 34179765
  13. 13

    Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis.

    Winter K, Nickell S, Powell M, Harriman K

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (64(1)):3-8 doi:10.1093/cid/ciw634.

    PMID: 27624955
  14. 14

    Predictors of Tdap vaccine acceptance in pregnancy before and after delivery.

    Toubiyan D, Fogel J, Jacobs AJ

    Therapeutic advances in vaccines and immunotherapy 2024; (12()):25151355241287689 doi:10.1177/25151355241287689.

    PMID: 39403252
  15. 15

    Association Between Third-Trimester Tdap Immunization and Neonatal Pertussis Antibody Concentration.

    Healy CM, Rench MA, Swaim LS, et al.

    JAMA 2018; (320(14)):1464-1470 doi:10.1001/jama.2018.14298.

    PMID: 30304426
  16. 16

    Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.

    Ozdil M, Sonmez C, Tugberk Bakar M, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2021; (265()):212-216 doi:10.1016/j.ejogrb.2021.08.033.

    PMID: 34534737
  17. 17

    Effectiveness of 5-pertussis-component tetanus, diphtheria, and acellular pertussis (Tdap5) vaccination in pregnancy at preventing infant pertussis.

    Hsiao A, Bartlett J, Fireman B, et al.

    American journal of obstetrics and gynecology 2026; (234(4)):1172-1182 doi:10.1016/j.ajog.2025.11.025.

    PMID: 41276201
  18. 18

    Case-Control Study to Estimate the Association Between Tdap Vaccination During Pregnancy and Reduced Risk of Pertussis in Newborn Infants in Peru, 2019-2021.

    Juscamayta-López E, Valdivia F, Soto MP, et al.

    Open forum infectious diseases 2023; (10(7)):ofad325 doi:10.1093/ofid/ofad325.

    PMID: 37469614
  19. 19

    Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementation.

    Lumbreras Areta M, Eberhardt CS, Siegrist CA, Martinez de Tejada B

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2019; (32(9)):1541-1546 doi:10.1080/14767058.2017.1406475.

    PMID: 29199493
  20. 20

    Cocooning strategy: Pertussis vaccination coverage rate of parents with a new-born in 2016 and 2017 in France.

    Marchal C, Belhassen M, Guiso N, et al.

    Frontiers in pediatrics 2022; (10()):988674 doi:10.3389/fped.2022.988674.

    PMID: 36330369
  21. 21

    [Should French pregnant women be vaccinated against pertussis during pregnancy?]

    Hattabi H, Bouchez C, Dubos F, et al.

    Gynecologie, obstetrique, fertilite & senologie 2022; (50(6)):486-493 doi:10.1016/j.gofs.2022.02.081.

    PMID: 35483610
  22. 22

    Knowledge and attitude factors associated with the prevalence of Tdap (tetanus, diphtheria, and acellular pertussis) booster vaccination in healthcare workers in a large academic hospital in Southern Italy in 2022: a cross-sectional study.

    Mercogliano M, Fiorilla C, Esposito F, et al.

    Frontiers in public health 2023; (11()):1173482 doi:10.3389/fpubh.2023.1173482.

    PMID: 37522000
  23. 23

    Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose.

    Halperin SA, Donovan C, Marshall GS, et al.

    Journal of the Pediatric Infectious Diseases Society 2019; (8(2)):105-114 doi:10.1093/jpids/pix113.

    PMID: 29438562

This page is for educational purposes only and does not replace professional medical advice regarding pertussis recovery or vaccination schedules. Always consult your healthcare provider or pediatrician about specific symptoms and vaccines.

Get notified when new evidence is published on Whooping cough.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.